Literature DB >> 3002807

Endothelial alpha 2-adrenoceptors in canine pulmonary and systemic blood vessels.

V M Miller, P M Vanhoutte.   

Abstract

The present study was designed to determine whether alpha 2-adrenoceptors mediate endothelium-dependent relaxations in veins and arteries of the pulmonary and systemic vasculature of the dog. Rings of either pulmonary or femoral artery and vein with and without endothelium were suspended for isometric force measurements in a buffered salt solution (37 degrees C; gassed with 95% O2 and 5% CO2). Removal of the endothelium caused a shift to the left of the concentration-response curves to epinephrine, norepinephrine and the selective alpha 2-adrenoceptor agonist UK 14,304, but not of that to the selective alpha 1-adrenoceptor agonist phenylephrine. In the presence of alpha 1- and beta-adrenoceptor blockers, norepinephrine and UK 14,304 initiated relaxations of previously contracted rings. These relaxations were inhibited by the alpha 2-adrenoceptor antagonist, rauwolscine, and were absent in rings without endothelium. In the pulmonary artery and femoral vein, the endothelium-dependent responses to UK 14,304 were masked in part by direct alpha 2-adrenergic activation of the vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3002807     DOI: 10.1016/0014-2999(85)90670-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  27 in total

1.  Cooling and response to adrenoceptor agonists of rabbit ear and femoral artery: role of the endothelium.

Authors:  A L García-Villalón; L Monge; J J Montoya; J L García; N Fernández; B Gómez; G Diéguez
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

2.  Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.

Authors:  G Lembo; G Iaccarino; C Vecchione; E Barbato; R Izzo; D Fontana; B Trimarco
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Systemic vascular endothelial cell dysfunction in normal pressure glaucoma.

Authors:  Christine Buckley; Patrick W F Hadoke; Emer Henry; Colm O'Brien
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

4.  Pharmacological evidence that alpha1-and alpha2-adrenoceptors mediate vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs.

Authors:  E W Willems; M Trion; P De Vries; J P Heiligers; C M Villalón; P R Saxena
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

5.  Conditions permitting suppression of stretch-induced and vasoconstrictor tone by basal nitric oxide activity in porcine cerebral artery.

Authors:  S J Wallis; W Martin
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 6.  Localization of α-adrenoceptors: JR Vane Medal Lecture.

Authors:  John C McGrath
Journal:  Br J Pharmacol       Date:  2015-03       Impact factor: 8.739

7.  EDRF-mediated dilatation in the rat isolated perfused kidney: a microangiographic study.

Authors:  G A Burton; T M Griffith; D H Edwards
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

8.  Centrally acting imidazolines stimulate vascular alpha 1A-adrenergic receptors in Rat-Tail Artery.

Authors:  Wentsworth B Kennedy; Louis Crane; Ramon R Gonzalez; Oommen K George; Lincoln P Edwards
Journal:  Cell Mol Neurobiol       Date:  2006-08-02       Impact factor: 5.046

9.  Differential sensitivity of basal and acetylcholine-induced activity of nitric oxide to blockade by asymmetric dimethylarginine in the rat aorta.

Authors:  Mohammed J Al-Zobaidy; John Craig; William Martin
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

10.  Endothelial overexpression of endothelin-1 modulates aortic, carotid, iliac and renal arterial responses in obese mice.

Authors:  Oliver Baretella; Sookja K Chung; Aimin Xu; Paul M Vanhoutte
Journal:  Acta Pharmacol Sin       Date:  2017-02-20       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.